Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: High expectations

In that case you're likely to be disappointed.  Do you expect the current quarter to show an increase in EPS over the quarter to be reported tomorrow?  I sure don't.  The "lumpy" nature of the licensing flow will cause periodic drops, quarter to quarter, and mgt needs to constantly reinforce that fact in its PR's and earnings releases.  That is also why it would be so difficult for mgt. to issue forward-looking guidance.  I would agree the overall EPS trend line, however, should be going up.  But it will be a bumpy ride, IMHO.

I (again) topped off the tank today at .515.  The share price can now go up.  You're welcome.  GLTAL.

Share
New Message
Please login to post a reply